MicroRNA‐155 inhibits dengue virus replication by inducing heme oxygenase‐1‐mediated antiviral interferon responses. Issue 6 (11th April 2020)

• Record Type: Journal Article
• Authors: Su, Yu‐Chieh; Huang, Yi‐Fang; Wu, Yu‐Wen; Chen, Hui‐Feng; Wu, Yu‐Hsuan; Hsu, Chia‐Chun; Hsu, Yao‐Chin; Lee, Jin‐Ching
• Is Part Of: FASEB journal. Volume 34:Issue 6(2020)
• Page Start: 7283
• Page End: 7294
• Publication Date: 2020-04-11
• Subjects: dengue virus -- heme oxygenase‐1 -- interferon -- microRNA -- protease; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.201902878R
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: MicroRNAs (miRNAs) have been reported to directly alter the virus life cycle and virus–host interactions, and so are considered promising molecules for controlling virus infection. In the present study, we observed that miR‐155 time‐dependently downregulated upon dengue virus (DENV) infection. In contrast, exogenous overexpression of miR‐155 appeared to limit viral replication in vitro, suggesting that the low levels of miR‐155 would be beneficial for DENV replication. In vivo, overexpression of miR‐155 protected ICR suckling mice from the life‐threatening effects of DENV infection and reduced virus propagation. Further investigation revealed that the anti‐DENV activity of miR‐155 was due to target Bach1, resulting in the induction of the heme oxygenase‐1 (HO‐1)‐mediated inhibition of DENV NS2B/NS3 protease activity, ultimately leading to induction of antiviral interferon responses, including interferon‐induced protein kinase R (PKR), 2′‐5′‐oligoadenylate synthetase 1 (OAS1), OAS2, and OAS3 expression, against DENV replication. Collectively, our results provide a promising new strategy to manage DENV infection by modulation of miR‐155 expression.